Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 25 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT05269381
- Conditions
- Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +165 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Recruiting
Agnostic Therapy in Rare Solid Tumors
NCT06638931
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +131 more
- Locations
-
- Hospital São Carlos Fortaleza, Ceará, Brazil
- Hospital São Rafael Salvador, Estado de Bahia, Brazil
- Hospital Santa Cruz Curitiba, Paraná, Brazil
- IDOR Recife Recife, Pernambuco, Brazil
NCT05646316
- Conditions
- Carcinosarcoma, Neoplasms, Neoplasms by Histologic Type, +4 more
- Locations
-
- George Washington University Medical Center Washington D.C., District of Columbia, United States
- UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
- UM Sylvester Comprehensive Cancer Center at Doral Doral, Florida, United States
NCT05500391
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Aggressive Fibromatosis of Abdominal Wall (Disorder), +33 more
- Locations
-
- CHU Amiens Amiens, France
- Centre François Baclesse Caen, France
- Centre Oscar Lambret Lille, France
Recruiting
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
NCT06349642
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +83 more
- Locations
-
- Mayo Clinic in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT04122872
- Conditions
- Carcinosarcoma, Neoplasms, Neoplasms by Histologic Type, +8 more
- Locations
-
- Universitätsklinikum Tübingen Tübingen, Baden-Wurttemberg, Germany
- Universitätsklinikum Erlangen Erlangen, Bavaria, Germany
- HELIOS Klinikum Bad Saarow Bad Saarow, Germany
- HELIOS Klinikum Berlin-Buch Berlin, Germany
NCT05542407
- Conditions
- Body Weight, Carcinosarcoma, Clear Cell Endometrial Carcinoma, +33 more
- Locations
-
- Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
Not Yet Recruiting
Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial
NCT07723235
- Conditions
- Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, +21 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT04458597
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +30 more
- Locations
-
- London Regional Cancer Program London, Ontario, Canada
NCT03395080
- Conditions
- Adnexal Diseases, Carcinosarcoma, Endocrine Gland Neoplasms, +23 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- HonorHealth Scottsdale, Arizona, United States
- Florida Cancer Specialists & Research Institute West Palm Beach, Florida, United States
- University of Chicago Chicago, Illinois, United States
Completed
ZW25 in Women With Endometrial Cancers
NCT04513665
- Conditions
- Carcinosarcoma, Endometrial Cancer, Endometrial Neoplasms, +15 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited protocol activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited protocol activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
NCT03241745
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +25 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack Commack, New York, United States
Completed
Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary
NCT03206177
- Conditions
- Carcinosarcoma, Carcinosarcoma, Ovarian, Neoplasms, +4 more
- Locations
-
- Stephenson Cancer Center, University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
NCT02993705
- Conditions
- Carcinosarcoma, Carcinosarcoma, Ovarian, Carcinosarcomas Uterine, +5 more
- Locations
-
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome, Italy
NCT00815945
- Conditions
- Carcinosarcoma, Leiomyosarcoma, Mesenchymal Tumor, +6 more
- Locations
-
- Charité, Campus Virchow Klinikum, Frauenklinik Berlin, Germany
- Malteser Krankenhaus, Gynäkologie und Geburtshilfe Bonn, Germany
- Klinikum Bremen-Mitte gGmbH, Frauenklinik Bremen, Germany
- Universitätsklinikum Carl Gustav Carus, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe Dresden, Germany
NCT00413322
- Conditions
- Adenoma, Adenosarcoma, Adnexal Diseases, +92 more
- Locations
-
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- University of Nebraska Omaha, Nebraska, United States
- Portsmouth Regional Hospital Hematology/Oncology Clinic Portsmouth, New Hampshire, United States
Active, Not Recruiting
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
NCT03914612
- Conditions
- Carcinosarcoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, +30 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
Active, Not Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer
NCT04214067
- Conditions
- Carcinosarcoma, Endometrial Endometrioid Adenocarcinoma, Neoplasms, +6 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Community Cancer Institute Clovis, California, United States
- University Oncology Associates Clovis, California, United States
- John Muir Medical Center-Concord Concord, California, United States
NCT03660826
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Active, Not Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
NCT04704661
- Conditions
- Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
- Locations
-
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States